# Ozempic Just Got Cheap Enough to Change the Entire World

Page: https://stenobird.com/podcast/good-revenue-6621493/ozempic-just-got-cheap-enough-to-change-the-entire-world
Text version: https://stenobird.com/podcast/good-revenue-6621493/ozempic-just-got-cheap-enough-to-change-the-entire-world.md
Podcast: [Good Revenue News](https://stenobird.com/podcast/good-revenue-6621493)
Published: 2026-03-27T13:00:00+00:00
Episode link: https://shows.acast.com/good-revenue/episodes/ozempic-boom-just-got-global-pricing-power-ai-targeting-to-r
Audio file: https://sphinx.acast.com/p/open/s/64c1fb4a8e16bd00116ffd75/e/69c5c1f8f4bf09c599ae04f8/media.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/good-revenue-6621493/episodes/ozempic-just-got-cheap-enough-to-change-the-entire-world
Duration seconds: 618

## Resource

A blockbuster drug collapsing from $1,000 to $15 looks like a pricing story. It isn’t. It is a signal that control over human behavior, demand, and consumption is shifting fast. Between generics, new science, and AI-driven optimization, entire industries tied to addiction, food, and habit-driven spending may face structural decline. This episode breaks down why this disruption was inevitable and what happens next. CHAPTERS 00:00 $1,000 drug drops to $15 overnight 00:30 The real story behind the price collapse 00:56 Patent cliff and global generics surge 01:40 Pricing pressure spreads beyond India 02:30 Who controls the pipeline 03:40 New research changes expectations 05:20 AI enters dosing and drug discovery 06:30 This becomes an economic story 07:00 Workforce and GDP implications 08:15 Spending shifts across industries 09:15 What breaks next SOURCES - Affordable GLP-1 Options Emerging in India and Beyond (CNBC): https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html - Global Impact of Ozempic Generics Expanding to China and Canada (NYT): https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html - Worldwide Reactions to Cheaper GLP-1 Drugs (BBC Analysis): https://www.bbc.com/news/articles/cx2g4411en3o - AI Optimizing Weight Loss Outcomes: https://www.sciencedirect.com/science/article/abs/pii/S2405457725003821 - Personalized Semaglutide Therapy with Artificial Intelligence: https://ai.jmir.org/2026/1/e86960 - Breakthroughs in GLP-1 Drug Engineering: https://www.sciencedirect.com/science/article/pii/S1359644625000467 - Cutting-Edge Ozempic Alternatives in Research: https://www.nature.com/articles/s41586-025-08683-y - Stanford Research on New Ozempic Rivals: https://med.stanford.edu…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/good-revenue-6621493/episodes/ozempic-just-got-cheap-enough-to-change-the-entire-world/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/good-revenue-6621493/ozempic-just-got-cheap-enough-to-change-the-entire-world.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.